PHARMALINK BASLÄKEMEDEL AB
Org. no. 979 808 399 · Utenlandsk enhet · Active · Fagerstagatan 18 B, S-163 53 SPÅNGA
Active
- Organisation form
- UTLA
- Employees
- Not registered
- Established
- 29 April 1998
- Municipality
- –
- Industry code
- –
PHARMALINK BASLÄKEMEDEL AB is a utenlandsk enhet registered in S-163 53 SPÅNGA since 1998. The organisation number is 979 808 399.
Source: The Brønnøysund Register Centre · Last updated 6 October 2026 at 03:49
Quick overview
Status and key figures
We have no submitted annual accounts for this company yet.
- Operating revenue
- –
- Net profit
- –
- Equity
- –
- Status
- Active
- Employees
- –
- Founded
- –
- Place
- S-163 53 SPÅNGA
- Industry
- –
- Public contracts
- –
- Roles
- 1
Central Coordinating Register
Registered in the Central Coordinating Register
People and entities
The gauges are calculated key figures with open thresholds, not a credit assessment. All amounts come from the Register of Company Accounts.
Registry data
Company information
- Organisation number
- 979 808 399
- Organisation form
- Utenlandsk enhet (UTLA)
- Registered in the Central Coordinating Register
- 29 April 1998
- Date of incorporation
- Not provided
- Number of employees
- No registered employees
- Language form
- Norwegian Bokmål
- Latest submitted annual accounts
- Not stated
- Deleted
- Not provided
- Website
- Not stated
- Bankruptcy date
- Not provided
Addresses
Visiting and postal address
Business address
Fagerstagatan 18 BS-163 53 SPÅNGASverigePostal address
c/o Pharmalink Norge AS, v/Per Mikael Bender, Kjelsåsveien 1740884 OSLOOSLO kommuneNorgeIndustry
Industry and sector
No industry code registered.
Registry status
Registrations and status
- Registered in the Register of Business Enterprises
- Registered in the VAT register
- Registered in the Register of Non-Profit Organisations
- Registered in the Register of Foundations
- Bankrupt
- In liquidation
- In compulsory liquidation
Experiences
Reviews
Loading reviews …
Write a review
You must sign in with a verified email to write a review.